The company's product candidates include Diazoxide Choline Controlled-Release tablets, an oral treatment for Prader-Willi Syndrome, a rare genetic disorder that causes obesity and other medical problems. Soleno Therapeutics is dedicated to improving the lives of patients with rare diseases by bringing innovative treatments to market.